PDCL2 and head and neck squamous cell carcinoma: The results suggested that AC117422.1, AC117422.1, AC128687.2, AL161431.1, and FCRL1 were elevated and LRADT1, PDCL2, PLA2G3, and SPRR3 were declined in the HNSCC samples (Figure 8(f)).